Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Novartis
Novartis
Novartis
Eli Lilly and Company
Teva Branded Pharmaceutical Products R&D, Inc.
INSYS Therapeutics Inc
Bristol-Myers Squibb